1. Payab M, Hasani-Ranjbar S, Shahbal N, Qorbani M, Aletaha A, Haghi-Aminjan H, et al. Effect of the herbal medicines in obesity and metabolic syndrome: A systematic review and meta-analysis of clinical trials. Phytother Res 2020; 34:526-545.
2. Najafi N, Mehri S, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review. Phytother Res 2022; 36:2300-2323.
3. Ghasemzadeh Rahbardar M, Ferns GA, Ghayour Mobarhan M. Vanillic acid as a promising intervention for metabolic syndrome: Preclinical studies. Iran J Basic Med Sci 2025; 28:141-150.
4. Ghasemzadeh Rahbardar M, Fazeli Kakhki H, Hosseinzadeh H. Ziziphus jujuba (Jujube) in Metabolic Syndrome: From Traditional Medicine to Scientific Validation. Curr Nutr Rep 2024; 13:845-866.
5. Yahyazadeh R, Ghasemzadeh Rahbardar M, Razavi BM, Karimi G, Hosseinzadeh H. The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review. Iran J Basic Med Sci 2021; 24:1462-1469.
6. Yarmohammadi F, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effect of eggplant (Solanum melongena) on the metabolic syndrome: A review. Iran J Basic Med Sci 2021; 24:420-427.
7. Oskouei Z, Ghasemzadeh Rahbardar M, Hosseinzadeh H. The effects of Dendrobium species on the metabolic syndrome: A review. Iran J Basic Med Sci 2023; 26:738-752.
8. Ardakanian A, Ghasemzadeh Rahbardar M, Omidkhoda F, Razavi BM, Hosseinzadeh H. Effect of alpha-mangostin on olanzapine-induced metabolic disorders in rats. Iran J Basic Med Sci 2022; 25:198-207.
9. Salehsari A, Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Investigating the effect of zeaxanthin on olanzapine-induced metabolic disorders in rats. Avicenna J Phytomed 2024; 14: 653-665.
10. Naraki K, Ghasemzadeh Rahbardar M, Ajiboye BO, Hosseinzadeh H. The effect of ellagic acid on the metabolic syndrome: A review article. Heliyon 2023; 9:e21844.
11. Jalali J, Ghasemzadeh Rahbardar M. Ameliorative effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: A review. J Ethnopharmacol 2022; 299:115672.
12. El-Sayed Moustafa JS, Froguel P. From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol 2013; 9:402-413.
13. Payab M, Kelishadi R, Qorbani M, Motlagh ME, Ranjbar SH, Ardalan G, et al. Association of junk food consumption with high blood pressure and obesity in Iranian children and adolescents: the CASPIAN-IV Study. J Pediatr 2015; 91:196-205.
14. Payab M, Kelishadi R, Qorbani M, Motlagh ME, Hasani-Ranjbar S, Ejtahed H-S, et al. Association of healthy foods intake with anthropometric measures and blood pressure in a national sample of Iranian children and adolescents: the CASPIAN-IV Study. Minerva Pediatrica 2016; 71:420-430.
15. Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi’i A. A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med 2021; 136:104754.
16. Fadishei M, Ghasemzadeh Rahbardar M, Imenshahidi M, Mohajeri A, Razavi BM, Hosseinzadeh H. Effects of Nigella sativa oil and thymoquinone against bisphenol A-induced metabolic disorder in rats. Phytother Res 2021; 35:2005-2024.
17. Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, et al. The role of adipokines in health and disease. Biomedicines 2023; 11:1290-1330.
18. Montan PD, Sourlas A, Olivero J, Silverio D, Guzman E, Kosmas CE. Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Ann Transl Med 2019; 7:393-399.
19. Hosseini M, Pkan P, Rakhshandeh H, Aghaie A, Sadeghnia HR, Rahbardar MG. The effect of hydro-alcoholic extract of citrus flower on pentylenetetrazole and maximal electroshock-induced seizures in mice. World Appl Sci J 2011; 15:1104-1109.
20. Mohammadi Zonouz A, Ghasemzadeh Rahbardar M, Hosseinzadeh H. The molecular mechanisms of ginkgo (Ginkgo biloba) activity in signaling pathways: A comprehensive review. Phytomedicine 2024; 126:155352.
21. Tandisehpanah Z, Foroutanfar A, Aziminia A, Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Protective effect of aqueous and ethanolic extracts of Lippia citriodora Kunth. on acrylamide-induced neurotoxicity. Avicenna J Phytomed 2022; 12:281-294.
22. Rajabalizadeh R, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Medicinal herbs in treating chemotherapy-induced nausea and vomiting: A review. Phytother Res 2022; 36:3691-3708.
23. Lin X, Li H. Obesity: Epidemiology, pathophysiology, and therapeutics. Front Endocrinol 2021; 12:706978.
24. Panic A, Stanimirovic J, Sudar-Milovanovic E, Isenovic ER. Oxidative stress in obesity and insulin resistance. Explor Med 2022; 3:58-70.
25. Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M. Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women? ARYA Atheroscler J 2010; 2:189-192.
26. Lingappan K. NF-κB in oxidative stress. Curr Opin Toxicol 2018; 7:81-86.
27. De Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc 2012; 71:332-338.
28. Shibabaw T, Dessie G, Molla MD, Zerihun MF, Ayelign B. Assessment of liver marker enzymes and its association with type 2 diabetes mellitus in Northwest Ethiopia. BMC Res Notes 2019; 12:707-711.
29. El-Eshmawy MM. Impact of obesity on liver function tests: is nonalcoholic fatty liver disease the only player? A review article. Porto Biomed J 2023; 8:e228.
30. Kwon OC, Han K, Park M-C. Higher gamma-glutamyl transferase levels are associated with an increased risk of incident systemic sclerosis: a nationwide population-based study. Sci Rep 2023; 13:21878.
31. Huang Z, Huang L, Waters MJ, Chen C. Insulin and growth hormone balance: implications for obesity. Trends Endocrinol Metab 2020; 31:642-654.
32. Koliaki C, Liatis S, Dalamaga M, Kokkinos A. The implication of gut hormones in the regulation of energy homeostasis and their role in the pathophysiology of obesity. Curr Obes Rep 2020; 9:255-271.
33. Picó C, Palou M, Pomar CA, Rodríguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord 2022; 23:13-30.
34. Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, et al. Leptin and obesity: Role and clinical implication. Front Endocrinol 2021; 12:585887.
35. Jung HN, Jung CH. The role of anti-inflammatory adipokines in cardiometabolic disorders: Moving beyond adiponectin. Int J Mol Sci 2021; 22:13529.
36. Castela I, Morais J, Barreiros-Mota I, Silvestre MP, Marques C, Rodrigues C, et al. Decreased adiponectin/leptin ratio relates to insulin resistance in adults with obesity. Am J Physiol Endocrinol Metab 2023; 324:E115-E119.
37. Akalu Y, Molla MD, Dessie G, Ayelign B. Physiological effect of ghrelin on body systems. Int J Endocrinol 2020; 2020:1385138.
38. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013; 5:1218-1240.
39. Williams A, Greene N, Kimbro K. Increased circulating cytokine levels in African American women with obesity and elevated HbA1c. Cytokine 2020; 128:154989.
40. Martins Kattah F, Janjusevic M, Figueiredo N, Santos Oliveira E, Carielo Lima G, Dâmaso AR, et al. HOMA-IR as a predictor of PAI-1 levels in women with severe obesity. Biomedicines 2024; 12:1222-1232.
41. Megawati G, Indraswari N, Johansyah AA, Kezia C, Herawati DMD, Gurnida DA, et al. Comparison of hs-CRP in adult obesity and central obesity in Indonesia based on omega-3 fatty acids intake: Indonesian family life survey 5 (IFLS 5) study. Int J Environ Res Public Health 2023; 20: 6734-6749.
42. Liu M, Wang P, Xie P, Xu X, He L, Chen X, et al. Expression of ICAM-1 and E-selectin in different metabolic obesity phenotypes: discrepancy for endothelial dysfunction. J Endocrinol Invest 2023; 46:2379-2389.
43. Wang S, Lin Y, Gao L, Yang Z, Lin J, Ren S, et al. PPAR-γ integrates obesity and adipocyte clock through epigenetic regulation of Bmal1. Theranostics 2022; 12:1589-1606.
44. Mariani S, Di Giorgio MR, Rossi E, Tozzi R, Contini S, Bauleo L, et al. Blood SIRT1 shows a coherent association with leptin and adiponectin in relation to the degree and distribution of adiposity: a study in obesity, normal weight and anorexia nervosa. Nutrients 2020; 12:3506-3518.
45. Ayaz E, Alpsoy HC. Garlic (Allium sativum) and traditional medicine. Turk Parazitol Derg 2007; 31:145-149.
46. Badal DS, Dwivedi A, Kumar V, Singh S, Prakash A, Verma S, et al. Effect of organic manures and inorganic fertilizers on growth, yield and its attributing traits in garlic (Allium sativum L.). J Pharmacogn Phytochem 2019; 8:587-590.
47. El-Saber Batiha G, Magdy Beshbishy A, L GW, Elewa YHA, A AA-S, Abd El-Hack ME, et al. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): A review. Nutrients 2020; 12:872-892.
48. Rahman K. Historical perspective on garlic and cardiovascular disease. J Nutr 2001; 131:977s-979s.
49. Soleimani D, Paknahad Z, Askari G, Iraj B, Feizi A. Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Adv Biomed Res 2016; 5:2-7.
50. Mariam MBB. Effect of garlic powder consumption on body composition of postmenopausal women in Bangalore Int J Eng Sci Res 2018; 6:274-282.
51. Sangouni AA, Mohammad Hosseini Azar MR, Alizadeh M. Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. Complement Ther Med 2020; 51:102428.
52. Ettehad-Marvasti F, Ejtahed HS, Siadat SD, Soroush AR, Hoseini-Tavassol Z, Hasani-Ranjbar S, et al. Effect of garlic extract on weight loss and gut microbiota composition in obese women: A double-blind randomized controlled trial. Front Nutr 2022; 9:1007506.
53. Zadhoush R, Alavi-Naeini A, Feizi A, Naghshineh E, Ghazvini MR. The therapeutic impact of garlic (Allium Sativum) on oxidative stress markers among polycystic ovary syndrome patients: A randomized, double-blinded clinical trial. Int J Prev Med 2023; 14:1-7.
54. Yoshitomi R, Yamamoto M, Kumazoe M, Fujimura Y, Yonekura M, Shimamoto Y, et al. The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial. Sci Rep 2021; 11:19067.
55. Samanta S. Potential bioactive components and health promotional benefits of tea (Camellia sinensis). J Am Nutr Assoc 2022; 41:65-93.
56. Forester SC, Lambert JD. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res 2011; 55:844-854.
57. Ohishi T, Goto S, Monira P, Isemura M, Nakamura Y. Anti-inflammatory action of green tea. Antiinflamm Antiallergy Agents Med Chem 2016; 15:74-90.
58. Xu J, Xu Z, Zheng W. A review of the antiviral role of green tea catechins. Molecules 2017; 22:1337-1354.
59. Gopal J, Muthu M, Paul D, Kim DH, Chun S. Bactericidal activity of green tea extracts: the importance of catechin containing nano particles. Sci Rep 2016; 6:19710.
60. Malar DS, Prasanth MI, Brimson JM, Sharika R, Sivamaruthi BS, Chaiyasut C, et al. Neuroprotective properties of green tea (Camellia sinensis) in Parkinson’s disease: A review. Molecules 2020; 25:3926-3947.
61. Rashidi B, Malekzadeh M, Goodarzi M, Masoudifar A, Mirzaei H. Green tea and its anti-angiogenesis effects. Biomed Pharmacother 2017; 89:949-956.
62. Di Pierro F, Menghi AB, Barreca A, Lucarelli M, Calandrelli A. Greenselect phytosome as an adjunct to a low-calorie diet for treatment of obesity: A clinical trial. Altern Med Rev 2009; 14:154-160.
63. Wang H, Wen Y, Du Y, Yan X, Guo H, Rycroft JA, et al. Effects of catechin enriched green tea on body composition. Obesity 2010; 18:773-779.
64. Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: Randomised, double-blind, placebo-controlled clinical trial. Br J Nutr 2013; 111:1263-1271.
65. Janssens PL, Hursel R, Westerterp-Plantenga MS. Long-term green tea extract supplementation does not affect fat absorption, resting energy expenditure, and body composition in adults. J Nutr 2015; 145:864-870.
66. Chen IJ, Liu CY, Chiu JP, Hsu CH. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2016; 35:592-599.
67. Nabi BN, Sedighinejad A, Haghighi M, Farzi F, Rimaz S, Atrkarroushan Z, et al. The anti-obesity effects of green tea: A controlled, randomized, clinical trial. Iran Red Crescent Med J 2018; 20:1-7.
68. Ranasinghe P, Pigera S, Premakumara GA, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complement Altern Med 2013; 13:275-284.
69. Tayebe Z, Fatemeh Esmaeli S, Rasol Z. The effect of oral supplementation of cinnamon on weight loss and blood pressure in patients with type 2 diabetes: a randomized clinical trial. J Med Plants Econ Dev 2017; 3:1-6.
70. Vafa M, Mohammadi F, Shidfar F, Sormaghi MS, Heidari I, Golestan B, et al. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med 2012; 3:531-536.
71. Borzoei A, Rafraf M, Asghari-Jafarabadi M. Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 2018; 27:556-563.
72. Sfar M, Hfaiedh KB, Mahrez KB, Skhiri HA, Rayana CB, Chemli R, et al. Effect of cinnamon supplementation on resistin and ghrelin in obese diabetic men. Indian J Tradit Knowl 2019; 18:694-701.
73. Dastgheib M, Barati-Boldaji R, Bahrampour N, Taheri R, Borghei M, Amooee S, et al. A comparison of the effects of cinnamon, ginger, and metformin consumption on metabolic health, anthropometric indices, and sexual hormone levels in women with poly cystic ovary syndrome: A randomized double-blinded placebo-controlled clinical trial. Front Nutr 2022; 9:1071515.
74. Zareie A, Bagherniya M, Sahebkar AH, Sharma M, Khorvash F, Hasanzadeh A, et al. Effects of cinnamon on anthropometric indices and headache-related disability of patients with migraine: A randomized double-blind placebo-controlled trial. Avicenna J Phytomed 2024; 14:1-12.
75. Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, Soresi M, et al. Effectiveness of a food supplement based on glucomannan, D-chiro-inositol, Cinnamomum zeylanicum blume and inulin in patients with metabolic syndrome. Nutrients 2024; 16:249-259.
76. Kotanidou EP, Tsinopoulou VR, Giza S, Ntouma S, Angeli C, Chatziandreou M, et al. The effect of saffron Kozanis (Crocus sativus L.) supplementation on weight management, glycemic markers and lipid profile in adolescents with obesity: A double-blinded randomized placebo-controlled trial. Children 2023; 10:1814-1828.
77. Aminifard T, Mehri S, Ghasemzadeh Rahbardar M, Rajabian F, Khajavi Rad A, Hosseinzadeh H. Trans-sodium crocetinate suppresses apoptotic and oxidative response following myoglobin-induced cytotoxicity in HEK-293 cells. Iran J Basic Med Sci 2024; 27:768-774.
78. Naraki K, Ghasemzadeh Rahbardar M, Razavi BM, Aminifar T, Khajavi Rad A, Amoueian S, et al. The power of trans-sodium crocetinate: exploring its renoprotective effects in a rat model of colistin-induced nephrotoxicity. Naunyn Schmiedebergs Arch Pharmacol 2024; 397:10155-10174.
79. Vafaeipour Z, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effect of saffron, black seed, and their main constituents on inflammatory cytokine response (mainly TNF-α) and oxidative stress status: an aspect on pharmacological insights. Naunyn Schmiedebergs Arch Pharmacol 2023; 396:2241-2259.
80. Ghasemzadeh Rahbardar M, Hosseinzadeh H. A review of how the saffron (Crocus sativus) petal and its main constituents interact with the Nrf2 and NF-κB signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 2023; 396:1879-1909.
81. Zolfaghari Farajerdi M, Rajabian F, Razavi BM, Ghasemzadeh Rahbardar M, Khajavi Rad A, Amoueian S, et al. Evaluating the effect of crocin on contrast-induced nephropathy in rats. Avicenna J Phytomed 2025; 15:920-932.
82. Rajabian F, Mehri S, Razavi BM, Khajavi Rad A, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effect of trans-sodium crocetinate on contrast-induced cytotoxicity in HEK-293 cells. Iran J Basic Med Sci 2023; 26:148-156.
83. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Therapeutic potential of hypnotic herbal medicines: A comprehensive review. Phytother Res 2024; 38:3037-3059.
84. Rajabalizadeh R, Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Renoprotective effects of crocin against colistin-induced nephrotoxicity in a rat model. Iran J Basic Med Sci 2024; 27:151-156.
85. Rajabian F, Razavi BM, Mehri S, Amouian S, Ghasemzadeh Rahbardar M, Khajavi Rad A, et al. Evaluation of pathways involved in the protective effect of trans sodium crocetinate against contrast-induced nephropathy in rats. Naunyn Schmiedebergs Arch Pharmacol 2024; doi: 10.1007/s00210-024-03600-y.
86. Mohammadzadeh L, Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Crocin protects malathion-induced striatal biochemical deficits by inhibiting apoptosis and increasing α-synuclein in rats’ striatum. J Mol Neurosci 2022; 72:983-993.
87.Rahbardar MG, Hosseinzadeh H. Mechanisms of action of herbal antidepressants. The Neuroscience of Depression: Elsevier; 2021. p. 503-518.
88. Boskabady MH, Rahbardar MG, Jafari Z. The effect of safranal on histamine (H(1)) receptors of guinea pig tracheal chains. Fitoterapia 2011; 82:162-167.
89. Boskabady MH, Ghasemzadeh Rahbardar M, Nemati H, Esmaeilzadeh M. Inhibitory effect of Crocus sativus (saffron) on histamine (H1) receptors of guinea pig tracheal chains. Pharmazie 2010; 65:300-305.
90. Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res 2010; 30:305-313.
91. Abedimanesh N, Bathaie SZ, Abedimanesh S, Motlagh B, Separham A, Ostadrahimi A. Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease. J Cardiovasc Thorac Res 2017; 9:200-208.
92. Kermani T, Kazemi T, Molki S, Ilkhani K, Sharifzadeh G, Rajabi O. The efficacy of crocin of saffron (Crocus sativus L.) on the components of metabolic syndrome: A randomized controlled clinical trial. J Res Pharm Pract 2017; 6:228-232.
93. Karimi-Nazari E, Nadjarzadeh A, Masoumi R, Marzban A, Mohajeri SA, Ramezani-Jolfaie N, et al. Effect of saffron (Crocus sativus L.) on lipid profile, glycemic indices and antioxidant status among overweight/obese prediabetic individuals: A double-blinded, randomized controlled trial. Clin Nutr ESPEN 2019; 34:130-136.
94. Ebrahimi F, Sahebkar A, Aryaeian N, Pahlavani N, Fallah S, Moradi N, et al. Effects of saffron supplementation on inflammation and metabolic responses in type 2 diabetic patients: A randomized, double-blind, placebo-controlled trial. Diabetes Metab Syndr Obes 2019; 12:2107-2115.
95. Kavianipour F, Aryaeian N, Mokhtare M, Mirnasrollahiparsa R, Jannani L, Agah S, et al. The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double‐blind randomized clinical trial. Phytother Res 2020; 34:3367-3378.
96. Akhondzadeh S, Mostafavi SA, Keshavarz SA, Mohammadi MR, Hosseini S, Eshraghian MR. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression. J Clin Pharm Ther 2020; 45:134-143.
97. Heydarian A, Kashani AHF, Masoodi M, Aryaeian N, Vafa M, Tahvilian N, et al. Effects of saffron supplementation on serum inflammatory markers and quality of life in patients with ulcerative colitis: A double blind randomized controlled clinical trial. J Herb Med 2022; 36:100593.
98. Razavi BM, Ghasemzadeh Rahbardar M, Hosseinzadeh H. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytother Res 2021; 35:6489-6513.
99. Ghasemzadeh Rahbardar M, Taghavizadeh Yazdi ME, Beigoli S, Amin H, Boskabady MH. Exploring the role of curcumin, nanocurcumin, and a PPAR agonist in preventing paraquat-induced systemic inflammation and oxidative stress in rats. Iran J Basic Med Sci 2025; doi: 10.22038/ijbms.2025.82057.17753.
100. Ghasemzadeh Rahbardar M, Hosseinzadeh H. The ameliorative effect of turmeric (Curcuma longa Linn) extract and its major constituent, curcumin, and its analogs on ethanol toxicity. Phytother Res 2024; 38:2165-2181.
101. Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, et al. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial. Chin J Integr Med 2015; 21:332-338.
102. Parsons HA, Baracos VE, Hong DS, Abbruzzese J, Bruera E, Kurzrock R. The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. Oncotarget 2016; 7:20293-20304.
103. Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of non-alcoholic fatty liver disease with curcumin: A randomized placebo-controlled trial. Phytother Res 2016; 30:1540-1548.
104. Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G. The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial. Diabetol Metab Syndr 2019; 11:41-48.
105. Darmian MA, Hoseini R, Amiri E, Golshani S. How combined and separate aerobic training and turmeric supplementation alter lipid profile and glycemic status? A clinical trial in middle-aged females with type 2 diabetes and hyperlipidemia. Int Cardiovasc Res J 2021; 15:111-118.
106. Uchio R, Kawasaki K, Okuda-Hanafusa C, Saji R, Muroyama K, Murosaki S, et al. Curcuma longa extract improves serum inflammatory markers and mental health in healthy participants who are overweight: A randomized, double-blind, placebo-controlled trial. Nutr J 2021; 20:91-104.
107. de Sousa Guardiano Reis PC, Alves AGP, Guillo LA, de Sousa MAN, Trindade NR, Silva MS. Curcumin supplementation reduces blood glucose and serum lipids of Brazilian women with high waist circumference: a randomized clinical trial. Arch Endocrinol Metab 2022; 66:800-807.
108. Majeed M, Nagabhushanam K, Devarajan TV, Saklecha S, Reddy SVK, Mundkur L. A minor metabolite from Curcuma longa effective against metabolic syndrome: results from a randomized, double-blind, placebo-controlled clinical study. Food Funct 2023; 14:4722-4733.
109. Mohammadi Zonouz A, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Antidotal and protective effects of mangosteen (Garcinia mangostana) against natural and chemical toxicities: A review. Iran J Basic Med Sci 2023; 26:492-503.
110. Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Investigating the ameliorative effect of alpha-mangostin on development and existing pain in a rat model of neuropathic pain. Phytother Res 2020; 34:3211-3225.
111. Eisvand F, Imenshahidi M, Ghasemzadeh Rahbardar M, Tabatabaei Yazdi SA, Rameshrad M, Razavi BM, et al. Cardioprotective effects of alpha-mangostin on doxorubicin-induced cardiotoxicity in rats. Phytother Res 2022; 36:506-524.
112. Ghobakhlou F, Eisvand F, Razavi BM, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Evaluating the effect of alpha-mangostin on neural toxicity induced by acrylamide in rats. Environ Sci Pollut Res Int 2023; 30:95789-95800.
113. Wang MH, Zhang KJ, Gu QL, Bi XL, Wang JX. Pharmacology of mangostins and their derivatives: A comprehensive review. Chin J Nat Med 2017; 15:81-93.
114. Liu QY, Wang YT, Lin LG. New insights into the anti-obesity activity of xanthones from Garcinia mangostana. Food Funct 2015; 6:383-393.
115. Udani JK, Singh BB, Barrett ML, Singh VJ. Evaluation of mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study. Nutr J 2009; 8:48-54.
116. Xie Z, Sintara M, Chang T, Ou B. Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: a randomized, double-blind, placebo-controlled clinical trial. Food Sci Nutr 2015; 3:342-348.
117. Watanabe M, Gangitano E, Francomano D, Addessi E, Toscano R, Costantini D, et al. Mangosteen extract shows a potent insulin sensitizing effect in obese female patients: A prospective randomized controlled pilot study. Nutrients 2018; 10: 586-595.
118. Hosseini A, Mehri S, Aminifard T, Ghasemzadeh Rahbardar M, Nouripor S, Khajavi Rad A, et al. Renoprotective effect of thymoquinone against rhabdomyolysis-induced acute kidney injury in the rat model. Iran J Basic Med Sci 2024; 27:552-559.
119. Hosseini M, Mirkarimi S, Amini M, Mohtashami R, Kianbakht S, Fallah Huseini H. Effects of Nigella sativa L. seed oil in type II diabetic patients: A randomized, double-blind, placebo - controlled clinical trial. J Med Plants 2013; 12:93-99.
120. Farzaneh E, Nia FR, Mehrtash M, Mirmoeini FS, Jalilvand M. The effects of 8-week Nigella sativa supplementation and aerobic training on lipid profile and VO2 max in sedentary overweight females. Int J Prev Med 2014; 5:210-216.
121. Namazi N, Mahdavi R, Alizadeh M, Farajnia S. Oxidative stress responses to Nigella sativa oil concurrent with a Low-calorie diet in obese women: A randomized, double-blind controlled clinical trial. Phytother Res 2015; 29:1722-1728.
122. Mahdavi R, Namazi N, Alizadeh M, Farajnia S. Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: A randomized controlled clinical trial. Food Funct 2015; 6:2041-2048.
123. Heshmati J, Namazi N, Memarzadeh M-R, Taghizadeh M, Kolahdooz F. Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Food Res Int 2015; 70:87-93.
124. Mahdavi R, Namazi N, Alizadeh M, Farajnia S. Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial. J Clin Lipidol 2016; 10:1203-1211.
125. Mahdavi R, Alizadeh M, Namazi N, Farajnia S. Changes of body composition and circulating adipokines in response to Nigella sativa oil with a calorie restricted diet in obese women. J Herb Med 2016; 6:67-72.
126. Namazi N, Mahdavi R, Alizadeh M, Farajnia S. The effects of Nigella sativa oil with a balanced low-calorie diet on insulin resistance in obese women: Gene-intervention interactions. Curr Top Nutraceut Res 2016; 14:273.
127. Farhangi MA, Dehghan P, Tajmiri S. Powdered black cumin seeds strongly improves serum lipids, atherogenic index of plasma and modulates anthropometric features in patients with Hashimoto’s thyroiditis. Lipids Health Dis 2018; 17:59-65.
128. Moustafa HAM, El Wakeel LM, Halawa MR, Sabri NA, El-Bahy AZ, Singab AN. Effect of Nigella sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients. Endocrine 2019; 65:286-294.
129. Safi S, Razmpoosh E, Fallahzadeh H, Mazaheri M, Abdollahi N, Nazari M, et al. The effect of Nigella sativa on appetite, anthropometric and body composition indices among overweight and obese women: A crossover, double-blind, placebo-controlled, randomized clinical trial. Complement Ther Med 2021; 57:102653.
130. Mostafa TM, Hegazy SK, Elnaidany SS, Shehabeldin WA, Sawan ES. Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin. J Diabetes Complications 2021; 35:107947.
131. Hadi S, Daryabeygi-Khotbehsara R, Mirmiran P, McVicar J, Hadi V, Soleimani D, et al. Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial. Phytother Res 2021; 35:3747-3755.
132. Razmpoosh E, Safi S, Nadjarzadeh A, Salehi-Abargouei A, Mazaheri M, Mirmiran P, et al. Effects of Nigella sativa supplementation on blood concentration and mRNA expression of TNF-α, PPAR-γ and adiponectin, as major adipogenesis-related markers, in obese and overweight women: A crossover, randomised-controlled trial. Br J Nutr 2022:1-10.
133. Devi M, Dhanalakshmi S, Govindarajan GT, Tanisha B, Sonalika T, Ruth J, et al. A review on Phaseolus vulgaris Linn. Pharmacogn J 2020; 12: 1160-1164.
134. Rodríguez L, Mendez D, Montecino H, Carrasco B, Arevalo B, Palomo I, et al. Role of Phaseolus vulgaris L. in the prevention of cardiovascular diseases—cardioprotective potential of bioactive compounds. Plants 2022; 11:186-215.
135. Fantini N, Cabras C, Lobina C, Colombo G, Gessa GL, Riva A, et al. Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. J Agric Food Chem 2009; 57:9316-9323.
136. Câmara CR, Urrea CA, Schlegel V. Pinto beans (Phaseolus vulgaris L.) as a functional food: Implications on human health. Agriculture 2013; 3:90-111.
137. Peddio S, Padiglia A, Cannea FB, Crnjar R, Zam W, Sharifi‐Rad J, et al. Common bean (Phaseolus vulgaris L.) α‐amylase inhibitors as safe nutraceutical strategy against diabetes and obesity: An update review. Phytother Res 2022; 36:2803-2823.
138. Celleno L, Tolaini MV, D’Amore A, Perricone NV, Preuss HG. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 2007; 4:45-52.
139. Ramírez-Jiménez AK, Luzardo-Ocampo I, Cuellar-Nuñez ML, Anaya-Loyola MA, León-Galván MF, Loarca-Piña G. Daily intake of a Phaseolus vulgaris L. snack bar attenuates hypertriglyceridemia and improves lipid metabolism-associated plasma proteins in Mexican women: A randomized clinical trial. Front Nutr 2022; 9:890136.
140. Jäger R, Abou Sawan S, Purpura M, Grube B, Röske Y, De Costa P, et al. Proprietary alpha-amylase inhibitor formulation from white kidney bean (Phaseolus vulgaris L.) promotes weight and fat loss: a 12-week, double-blind, placebo-controlled, randomized trial. Sci Rep 2024; 14:12685.
141. Jalali J, Ghasemzadeh Rahbardar M. Ameliorative effects of Portulaca oleracea L. (purslane) and its active constituents on nervous system disorders: A review. Iran J Basic Med Sci 2023; 26:2-12.
142. Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Akbari-Fakhrabadi M, et al. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. Phytother Res 2021; 35:3145-3156.
143. Moslemi Z, Bahrami M, Hosseini E, Mansourian M, Daneshyar Z, Eftekhari M, et al. Portulaca oleracea methanolic extract attenuate bile duct ligation-induced acute liver injury through hepatoprotective and anti-inflammatory effects. Heliyon 2021; 7:e07604.
144. Tian X, Ding Y, Kong Y, Wang G, Wang S, Cheng D. Purslane (Portulacae oleracea L.) attenuates cadmium-induced hepatorenal and colonic damage in mice: Role of chelation, antioxidant and intestinal microecological regulation. Phytomedicine 2021; 92:153716.
145. Tian J, Ying Z, Lan X, Li Y, Leng A, Ying X. Two new metabolites from Portulaca oleracea and their anti-inflammatory activities. Phytochem Lett 2022; 48:114-119.
146. Ojah EO, Oladele EO, Chukwuemeka P. Phytochemical and antibacterial properties of root extracts from Portulaca oleracea Linn.(Purslane) utilised in the management of diseases in Nigeria. J Med Plants Econ Dev 2021; 5:103-109.
147. Al-Otibi F, Alfuzan SA, Alharbi RI, Al-Askar AA, Al-Otaibi RM, Al Subaie HF, et al. Comparative study of antifungal activity of two preparations of green silver nanoparticles from Portulaca oleracea extract. Saudi J Biol Sci 2022; 29:2772-2781.
148. Sangeetha S, Kiran RS, Abbulu K, Battu S. A review on traditional herb Portulaca oleracea. World J Pharm Res 2020; 9:578-601.
149. El-Sayed MI. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol 2011; 137:643-651.
150. Adelnia Najafabadi E, Dehghani A, Behradmanesh S, Najarzadeh A. The effect of purslane seeds on fasting blood glucose and serum liver enzymes in patients with nonalcoholic fatty livers. Iran J Diabetes Obes 2015; 7:163-171.
151. Esmaillzadeh A, Zakizadeh E, Faghihimani E, Gohari M, Jazayeri S. The effect of purslane seeds on glycemic status and lipid profiles of persons with type 2 diabetes: A randomized controlled cross-over clinical trial. J Res Med Sci 2015; 20:47-53.
152. Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Heshmati J, et al. Effect of Portulaca oleracea (purslane) extract on inflammatory factors in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. J Funct Foods 2023; 102:105465.
153. Tafti MA, Moein M, Babajafari S, Haem E, Zarshenas MM. Efficacy of herbal supplementation of purslane freeze-dried juice for weight loss: An 8-week randomized, double-blind, placebo-controlled clinical trial. Curr Tradit Med 2024; 10:81-90.
154. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Toxicity and safety of rosemary (Rosmarinus officinalis): A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2025; 398:9-23.
155. Rafie H, Soheila H, Grant E. Rosmarinus officinalis (rosemary): A novel therapeutic agent for antioxidant, antimicrobial, anticancer, antidiabetic, antidepressant, neuroprotective, anti-inflammatory and anti-obesity treatment. Biomed J Sci & Tech Res 2017; 1:1098-1103.
156. Ghasemzadeh Rahbardar M, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L. and rosmarinic acid in a rat model of neuropathic pain. Biomed Pharmacother 2017; 86:441-449.
157. Nakisa N. Therapeutic potential of rosemary (Rosmarinus officinalis L.) on sports injuries: A review of patents. Res J Pharmacogn 2022; 9:71-83.
158. Rahbardar MG, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: An evidence of anti-oxidative and anti-inflammatory effects. Phytomedicine 2018; 40:59-67.
159. Ghasemzadeh Rahbardar M, Hemadeh B, Razavi BM, Eisvand F, Hosseinzadeh H. Effect of carnosic acid on acrylamide induced neurotoxicity: in vivo and in vitro experiments. Drug Chem Toxicol 2022; 45:1528-1535.
160. Ghasemzadeh MR, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats. J Ethnopharmacol 2016; 194:117-130.
161. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders. Iran J Basic Med Sci 2020; 23:1100-1112.
162. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effects of rosmarinic acid on nervous system disorders: An updated review. Naunyn Schmiedebergs Arch Pharmacol 2020; 393:1779-1795.
163. Nakisa N, Rahbardar MG. Action mechanisms of antirheumatic herbal medicines. Rheumatoid Arthritis 2021;1-15.
164. Alavi MS, Fanoudi S, Ghasemzadeh Rahbardar M, Mehri S, Hosseinzadeh H. An updated review of protective effects of rosemary and its active constituents against natural and chemical toxicities. Phytother Res 2021; 35:1313-1328.
165. Rahbardar MG, Eisvand F, Rameshrad M, Razavi BM, Hosseinzadeh H. In vivo and in vitro protective effects of rosmarinic acid against doxorubicin-induced cardiotoxicity. Nutr Cancer 2022; 74:747-760.
166. Ghasemzadeh Rahbardar M, Eisvand F, Rameshrad M, Razavi BM, Tabatabaee Yazdi A, Hosseinzadeh H. Carnosic acid mitigates doxorubicin-induced cardiac toxicity: Evidence from animal and cell model investigations. Iran J Basic Med Sci 2024; 27:425-438.
167. Akbari S, Sohouli MH, Ebrahimzadeh S, Ghanaei FM, Hosseini AF, Aryaeian N. Effect of rosemary leaf powder with weight loss diet on lipid profile, glycemic status, and liver enzymes in patients with nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. Phytother Res 2022; 36:2186-2196.
168. Tremêa GTF, Kleibert KRU, Krause LS, Fell APW, Scapini AR, Marschall KW, et al. Aesthetic radiofrequency combined with oral supplementation with Rosmarinus officinalis changes anthropometric measures in women: Randomized clinical trial. Rev Bras Obes Nutr Emagrec 2023; 17:615-623.
169. Khazdair MR, Ghorani V, Alavinezhad A, Boskabady MH. Pharmacological effects of Zataria multiflora Boiss L. and its constituents focus on their anti-inflammatory, anti-oxidant, and immunomodulatory effects. Fundam Clin Pharmacol 2018; 32:26-50.
170. POWO. Plants of the World Online. Facilitated by the Royal Botanic Gardens, Kew. Published on the Internet 2025. Available from: https://powo.science.kew.org/taxon/urn%3Alsid%3Aipni.org%3Anames%3A461954-1.
171. Ghasemzadeh Rahbardar M, Khosravi R, Beigoli S, Sarbaz P, Amirahmadi S, Hosseini M, et al. Examining the preventive effect of Zataria multiflora Boiss on paraquat-induced behavioral impairment and hippocampal oxidative stress. Toxicol Environ Health Sci 2025; 1-14.
172. Boskabady MH, Jafari Z, Pouraboli I, Babazade B, Rahbardar MG. Anti-cholinergic effect of Zataria multiflora Boiss on guinea pig tracheal chains. Nat Prod Res 2012; 26:1523-1528.
173. Abolghasemi J, Farboodniay Jahromi MA, Hossein Sharifi M, Mazloom Z, Hosseini L, Zamani N, et al. Effects of Zataria oxymel on obesity, insulin resistance and lipid profile: A randomized, controlled, triple-blind trial. J Integr Med 2020; 18:401-408.
174. Sadeghi A, Gholami M, Matinhomaee H, Natanzi HA, Ghazalian F. Effects of an eight-week combined exercise training program with Zataria multiflora supplementation on levels of ANGPTL8, ICAM-1, and VCAM-1 in inactive obese men: A clinical trial. J Gorgan Univ Med Sci 2023; 25:1-10.
175. Mashhadi NS, Ghiasvand R, Askari G, Hariri M, Darvishi L, Mofid MR. Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: Review of current evidence. Int J Prev Med 2013; 4:S36-S42.
176. Mahluji S, Attari VE, Mobasseri M, Payahoo L, Ostadrahimi A, Golzari SE. Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. Int J Food Sci Nutr 2013; 64:682-686.
177. Palatty PL, Haniadka R, Valder B, Arora R, Baliga MS. Ginger in the prevention of nausea and vomiting: a review. Crit Rev Food Sci Nutr 2013; 53:659-669.
178. Habib SH, Makpol S, Abdul Hamid NA, Das S, Ngah WZ, Yusof YA. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics 2008; 63:807-813.
179. Saravanan G, Ponmurugan P, Deepa MA, Senthilkumar B. Anti-obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J Sci Food Agric 2014; 94:2972-2977.
180. Li Y, Tran VH, Kota BP, Nammi S, Duke CC, Roufogalis BD. Preventative effect of Zingiber officinale on insulin resistance in a high-fat high-carbohydrate diet-fed rat model and its mechanism of action. Basic Clin Pharmacol Toxicol 2014; 115:209-215.
181. Mahmoud RH, Elnour WA. Comparative evaluation of the efficacy of ginger and orlistat on obesity management, pancreatic lipase and liver peroxisomal catalase enzyme in male Albino rats. Eur Rev Med Pharmacol Sci 2013; 17:75-83.
182. Ebrahimzadeh Attari V, Asghari Jafarabadi M, Zemestani M, Ostadrahimi A. Effect of Zingiber officinale supplementation on obesity management with respect to the uncoupling protein 1‐3826A> G and ß3‐adrenergic receptor Trp64Arg polymorphism. Phytother Res 2015; 29:1032-1039.
183. Ebrahimzadeh Attari V, Ostadrahimi A, Asghari Jafarabadi M, Mehralizadeh S, Mahluji S. Changes of serum adipocytokines and body weight following Zingiber officinale supplementation in obese women: A RCT. Eur J Nutr 2016; 55:2129-2136.
184. El Gayar MH, Aboromia MMM, Ibrahim NA, Abdel Hafiz MH. Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus. Obes Med 2019; 14:100094.
185. Park SH, Jung SJ, Choi EK, Ha KC, Baek HI, Park YK, et al. The effects of steamed ginger ethanolic extract on weight and body fat loss: a randomized, double-blind, placebo-controlled clinical trial. Food Sci Biotechnol 2020; 29:265-273.
186. Braga Tibaes JR, Martins LB, Rodrigues A, Amaral MHA, Teixeira AL, Ferreira AVM. Ginger supplementation does not increase energy expenditure in female adults. Nutrition 2022; 103-104:111803.
187. Rafie R, Hosseini SA, Hajiani E, Saki Malehi A, Mard SA. Effect of ginger powder supplementation in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Clin Exp Gastroenterol 2020; 13:35-45.
188. Ghoreishi PS, Shams M, Nimrouzi M, Zarshenas MM, Lankarani KB, Fallahzadeh Abarghooei E, et al. The effects of ginger (Zingiber officinale Roscoe) on non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A randomized double-blinded placebo-controlled clinical trial. J Diet Suppl 2024; 21:294-312.
)